Time for action on drug safety
Shatin, D.; Gardner, J.S.; Stergachis, A.
JAMA 281(4): 319
1999
ISSN/ISBN: 0098-7484 PMID: 9929076 Document Number: 503120
Document emailed within 1 workday
Related Documents
Philippens, K.M. 1984: Morphology, function and time: its relation to drug action British Journal of Clinical Practice. Suppl 33: 8-15D'Arcy, P.F. 1999: Reactions and interactions of drugs. Safety measures from Drug Safety Committee of the United Kingdom Journal de Pharmacie de Belgique 54(2): 44-47
Scarsi, K.K.; Darin, K.M.; Chappell, C.A.; Nitz, S.M.; Lamorde, M. 2016: Drug-Drug Interactions, Effectiveness, and Safety of Hormonal Contraceptives in Women Living with HIV Drug Safety 39(11): 1053-1072
Dworacka, M.; Nowocień, T. 2017: Undesirable pharmacokinetic drug-to-drug interactions affecting the effectiveness and safety of anti-infectious pharmacotherapy Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 42(248): 61-64
Ecker-Schlipf, B. 1987: Disease and drug abuse. Current problems in drug safety Medizinische Monatsschrift für Pharmazeuten 10(8): 254-261
Leonard, B. 1987: Drug safety and drug toxicity: the Irish situation Irish Medical Journal 80(4): 106-107
Evens, R.P.; Yanchick, V. 1984: Unit-dose systems: drug waste and drug processing time in a long-term care facility Hospital Formulary 19(6): 454-458
Kornchankul, W.; Hamed, E.; Parikh, N.H.; Sakr, A. 2002: Effect of drug proportion and mixing time on the content uniformity of a low dose drug in a high shear mixer Die Pharmazie 57(1): 49-53
Lubawy, W.C.; Kostenbauder, H.B.; Stavchansky, S.A. 1974: Cross inhibition of drug metabolism by drug metabolites. Increase of zoxazolamine paralysis time by the major metabolite of diphenylhydantoin Research Communications in Chemical Pathology and Pharmacology 8(1): 75-82
Emilien, G.; Maloteaux, J.M. 1998: Pharmacological management of epilepsy. Mechanism of action, pharmacokinetic drug interactions, and new drug discovery possibilities International Journal of Clinical Pharmacology and Therapeutics 36(4): 181-194
Kimbel, K.H. 1978: Drug safety through drug legislation Der Internist 19(6): 326-332
Ahmed, S.Masud.; Naher, N.; Hossain, T.; Rawal, L.Bahadur. 2017: Exploring the status of retail private drug shops in Bangladesh and action points for developing an accredited drug shop model: a facility based cross-sectional study Journal of Pharmaceutical Policy and Practice 10: 21
Chorostowska-Wynimko, J. 2002: Mechanism of B2-agonists action and safety aspects Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 12(72): 441-444
Gray, L. 2014: ICD-10: time to take action Medical Economics 91(7): 36-39
Mishell, D.R. 1998: Intrauterine devices: mechanisms of action, safety, and efficacy Contraception 58(3 Suppl): 45s-53s; Quiz 70s
DeCherney, G.S. 1998: The FDA and drug safety Delaware Medical Journal 70(9): 405-406
Spencer, L. 1992: Hammer time--veterinary profession no longer on defense concerning food safety Journal of the American Veterinary Medical Association 200(9): 1197-1199
Rosenqvist, M.år.; Nordlander, R. 2003: Medical safety at our airports--time for an emergency team at the Arlanda airport Lakartidningen 100(36): 2785-2786
Oberpichler-Schwenk, H. 2009: Heparin - an example in drug safety Medizinische Monatsschrift für Pharmazeuten 32(1): 1
Nolan, E.J. 1991: Infants at risk: a time for action Pediatric Nursing 17(2): 175-178